Phase I Trial of BYL719 in Combination With Concurrent Cisplatin-based Chemoradiotherapy in Patients With Locoregionally Advanced Squamous Cell Carcinoma of Head and Neck (LA-SCCHN)
Latest Information Update: 20 Apr 2021
At a glance
- Drugs Alpelisib (Primary) ; Cisplatin; Ropidoxuridine
- Indications Head and neck cancer; Oropharyngeal cancer; Squamous cell cancer
- Focus Adverse reactions
- 16 Apr 2021 Status changed from active, no longer recruiting to completed.
- 17 Apr 2019 Planned End Date changed from 1 Mar 2020 to 1 Jan 2021.
- 17 Apr 2019 Status changed from recruiting to active, no longer recruiting.